• (NON-PEER REVIEWED) Loma Linda University, Loma Linda, CA-Principal Investigator-   Double-Blind, Vehicle-Controlled Study of Imiquimod Cream 5% in Pediatric Subjects with Molluscum Contagiosum to evaluate safety and efficacy of daily dosing during 8 weeks of treatment (10/2003 - 10/2004)
  • (NON-PEER REVIEWED) Co-Investigator  A multi-center, epidemiology study to evaluate the potential for adverse health effects in fetuses and live-born infants following a woman’s pregnancy, compared with a similar group of psoriatic women not exposed to tazarotene and compared with background levels in the general population. (01/2002 - 08/2006)
  • (NON-PEER REVIEWED) University of Massachusettes Medical Center, Worcester, MA Co-Investigator Randomized, clinical trial comparing cryotherapy and pulsed-dye laser in the treatment of plantar warts.          (06/1997 - 09/1999)
  • (NON-PEER REVIEWED) Boston University School of Medicine, Boston, MA Barbara Gilchrest, M.D. and Hee-Yound Park, Ph.D. Examination of the role of protein kinase C in pigmentation.  (11/1993 - 03/1994)
  • (NON-PEER REVIEWED) University of California Los Angeles School of Medicine Robert Modlin, M.D. Study of T-cells bearing V6 T-cell receptors in leprosy. (03/1993 - 10/1993)
  • (NON-PEER REVIEWED) Pasteur Institute, Paris, France Paul Brey, Ph.D. Variation of mosquito larvae susceptibility to Lagenidium Giganteum. (08/1988 - 08/1989)

Book Review - Scholarly Journals--Published

  • Golkar L, LeBrun RA, Ohayon H, Gounon P, Papierok B, Brey PT. Variation of larval susceptibility to Lagenidium giganteum in three mosquito species.  J Invertebrate Pathology 1993; 62: 1 - 8. (Present)
  • Wang XH, Golkar L, Uyemura K, Ohmen JD, Villahermosa LG, Fajardo TT, Cellona RV,  Walsh GP,  Modlin RL. T cells bearing V6 T-cell receptors in the cell-mediated immune response to mycobacterium leprae. J Immunology  1993;  151:7105-16. (Present)
  • Sieling PA, Wang XH, Gately MK, Oliveros JL, McHugh T, Barnes PF, Wolf SF, Golkar L, Yamamura M et al. IL-12 regulates T-helper type 1 cytokine responses in human infectious disease. J Immunology  1994; 153: 3639-47. (Present)
  •   Golkar L, Bernhard JD.  Mastocytosis. Lancet  1997; 349: 1379-85. (Present)
  • Golkar L, Eichenfield LF.  Xerosis and systemic disease: are you undertreating your             dry skin patients? Skin and Aging  1998; 6: 35-38. (Present)
  • Monshizadeh R, Golkar L. Cohen L, Rubin P. Perforating follicular cyst of the tarsus. J am Acad Dermatol. 2003;48: S33-34 (Present)
  • Chang Y, Golkar L. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case. Pediatr  Dermatol. 2008;25:403-4 (Present)